Review
Published on 20 Nov 2025
Research progress on the use of polyphenols in the treatment of Crohn’s disease
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1704901
- 159 views
Type at least 3 characters
1,264 articles
Systematic Review
Published on 20 Nov 2025
Therapeutic effect and safety of Wei-Fu-Chun in the treatment of chronic atrophic gastritis: a network meta-analysis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1693427
- 119 views
Systematic Review
Published on 19 Nov 2025
Metformin for primary prevention of colorectal neoplasms in adenoma-free populations: a systematic review and dose-response meta-analysis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1645387
- 241 views
Original Research
Published on 18 Nov 2025
Glial cell line-derived neurotrophic factor inhibits mast-cell-like RBL-2H3 cells activation via Ca2+-mediated degranulation and Ca2+/CaMKⅡ/JNK pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1697815
- 303 views
Systematic Review
Accepted on 17 Nov 2025
Mesenchymal Stem Cell–Derived Small Extracellular Vesicles (sEVs) as a Therapy for Sepsis-Related Liver Injury: Evidence from a Systematic Review and Meta-Analysis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
Original Research
Accepted on 14 Nov 2025
SLC11A1 Protein as a Key Regulator of Iron Metabolism, Ferroptosis Mediator, and Putative Therapeutic Target in Nonalcoholic Fatty Liver Disease: An Integrated Bioinformatics Analysis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
- 101 views
Systematic Review
Published on 14 Nov 2025
Different nucleos(t)ide analogs in resected hepatitis B virus-associated hepatocellular carcinoma: a systematic review
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1647888
- 327 views
Original Research
Accepted on 12 Nov 2025
Lycii Radicis Cortex Alleviates Fibrosis in hiPSC-Derived Multilineage Hepatic Organoids via the cAMP-PKA Pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
- 150 views
Original Research
Published on 12 Nov 2025
Pharmacovigilance study of the frequency of gastrointestinal ulceration reports associated with immune checkpoint inhibitors: insights from the FDA adverse event reporting system
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1682259
- 330 views
Original Research
Accepted on 10 Nov 2025
Disrupting Cell Death: Ferroptosis & Pyroptosis Inhibition in Hepatic Ischemia-Reperfusion Injury via modulation of GPX4 and cGAS pathways by Deferoxamine and Octreotide
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
Mini Review
Published on 10 Nov 2025
Immunometabolic integration in therapeutic strategies for managing MASLD
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1693753
- 896 views
Original Research
Published on 07 Nov 2025
Cistanche deserticola-derived exosome-like nanovesicles target the Microbiota-GABA signaling axis to ameliorate loperamide-induced constipation
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1693366
- 660 views
Brief Research Report
Published on 07 Nov 2025
Salivary oxidative stress persists in inflammatory bowel disease regardless of biological treatment response
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1699252
- 645 views
Perspective
Published on 05 Nov 2025
Not quite a cure yet: unlocking the unfulfilled promise of live biotherapeutics for disease treatment
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1695976
- 648 views
Original Research
Accepted on 04 Nov 2025
The therapeutic efficacy of radical resection for hepatocellular carcinoma varied markedly with tumor location, based on real-world data from a retrospective single-centre analysis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
- 129 views
Original Research
Published on 04 Nov 2025
Oral administration of the probiotic strain Lactobacillus helveticus BGRA43 reduces high-fat diet–induced hepatic steatosis in mice and restores gut microbiota composition
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1688777
- 645 views